
Prescription required — provider reviewed
Free discreet shipping in the US
Tirzepatide Injectable
Dual GIP/GLP-1 agonist — next-generation weight loss
$349.00
Includes provider review, pharmacy fulfillment, and shipping.
Prescription tirzepatide for weight management, monitored by licensed providers. Choose a Monthly dose, a 3 month bundle (Months 1–3), or a 3 month bundle (Months 4–6).
Availability depends on where you live and where your order will ship.
Choose your plan
Key benefits
What this protocol supports
Supports weight management alongside diet and lifestyle changes
Dual-action: targets both GIP and GLP-1 receptors
Acts on two appetite-related receptor pathways
Once-weekly injection
Ongoing provider monitoring and dose titration
How it works
From intake to your doorstep
Complete a brief online health assessment
Provider review within 24 hours
Compounded medication shipped to your door
Ongoing dose titration and monthly check-ins
The science
Why it works
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It is prescribed for weight management alongside diet and lifestyle changes, with dosing individualized by your provider.
Trust & safety
Clinical care, not a supplement store
Licensed provider review
Every order is reviewed by a US-licensed clinician before it ships. No prescription, no charge.
US compounding pharmacies
Formulated in FDA-registered, state-licensed pharmacies with batch testing on every lot.
Discreet cold-chain shipping
Temperature-controlled, unbranded packaging with tracking from door to door.
Cancel or pause anytime
No lock-in contracts. Adjust dosing or pause your program with your care team.
FAQs
Questions patients ask
Tirzepatide acts on two receptors (GIP + GLP-1), while semaglutide acts on one (GLP-1). Your provider will discuss which may be appropriate for you.
Nausea, constipation, and mild fatigue are most common, especially during dose increases. These typically subside within a few weeks.
Ready to start Tirzepatide Injectable?
Complete your intake in minutes — a licensed provider reviews it within 24 hours.



